STAT3 and cancer: While constitutive or inappropriate STAT3 activation is clearly a common pathogenic event in cancer development, and targeting this transcription factor can mediate therapeutic benefit, an understanding of these complex dynamics will likely allow a more refined and successful approach to cancer therapy.